Cerebral ischemia and neuroregeneration

Area of Science:

• Neuroscience
• Neurology
• Pathophysiology

Background:

• Cerebral ischemia, including stroke, is a significant global health burden.
• Current treatments for cerebral ischemia are limited, with few effective options beyond anti-thrombolytics and hypothermia.
• The high and increasing economic impact of stroke underscores the need for new therapeutic strategies.

Purpose of the Study:

• To review the mechanisms of brain injury caused by cerebral ischemia.
• To discuss current and emerging therapeutic approaches for treating cerebral ischemia and stroke.
• To highlight the urgent need for novel treatments to reduce morbidity and mortality.

Main Methods:

• Literature review of mechanisms underlying cerebral ischemia-induced brain injury.
• Analysis of existing and potential novel therapeutic strategies.
• Discussion of therapeutic targets including growth factors, metabolic modulators, and cell-based therapies.

Main Results:

• Cerebral ischemia leads to complex pathophysiological processes causing neuronal damage.
• Several novel therapeutic avenues show promise, including growth factors, NAD+, melatonin, resveratrol, PKC isozymes, pifithrin, hypothermia, fatty acids, sympathoplegic drugs, and stem cells.
• Existing therapies have limitations in reducing neuronal injury, neurological deficits, and mortality.

Conclusions:

• Novel therapeutic strategies are essential to address the limitations of current treatments for cerebral ischemia.
• A deeper understanding of ischemia's mechanisms can guide the development of more effective interventions.
• Targeting pathways with agents like growth factors, NAD+, and stem cells offers potential for improved stroke outcomes.